However, there was no statistical difference in the mRNA expression of FABP4 and MAPT between tumor tissues and normal tissues of COAD patients, but the downward trend of FABP4 and MAPT expression in tumor tissues could still be seen, which may need to be verified by more clinical samples. This evidence concerns the gene FABP4 and colon adenocarcinoma.